sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Oncology Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Oncology Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :110
Published Date : 2020-12-15

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Oncology Drug Market with our analysts monitoring the situation across the globe.
Oncology Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Oncology Drug market is segmented into Chemotherapy Targeted Therapy Immunotherapy Hormonal Therapy Others Segment by Application, the Oncology Drug market is segmented into Blood Cancer Breast Cancer gastrointestinal Tract Cancer Prostate Cancer Lung Cancer Skin Cancer Regional and Country-level Analysis The Oncology Drug market is analysed and market size information is provided by regions (countries). The key regions covered in the Oncology Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Oncology Drug Market Share Analysis Oncology Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology Drug business, the date to enter into the Oncology Drug market, Oncology Drug product introduction, recent developments, etc. The major vendors covered: Roche Ltd Novartis AG Bristol-Myers Squibb Celgene Corporation Johnson & Johnson Pfizer Inc. Astra Zenca Plc Eli Lilly And Company. Glaxosmithkline Plc Merck & Co. Sanofi Amgen Inc. Abbvie
1 Study Coverage 1.1 Oncology Drug Product Introduction 1.2 Market Segments 1.3 Key Oncology Drug Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Oncology Drug Market Size Growth Rate by Type 1.4.2 Chemotherapy 1.4.3 Targeted Therapy 1.4.4 Immunotherapy 1.4.5 Hormonal Therapy 1.4.6 Others 1.5 Market by Application 1.5.1 Global Oncology Drug Market Size Growth Rate by Application 1.5.2 Blood Cancer 1.5.3 Breast Cancer 1.5.4 gastrointestinal Tract Cancer 1.5.5 Prostate Cancer 1.5.6 Lung Cancer 1.5.7 Skin Cancer 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Oncology Drug Market Size, Estimates and Forecasts 2.1.1 Global Oncology Drug Revenue 2015-2026 2.1.2 Global Oncology Drug Sales 2015-2026 2.2 Global Oncology Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Oncology Drug Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Oncology Drug Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Oncology Drug Competitor Landscape by Players 3.1 Oncology Drug Sales by Manufacturers 3.1.1 Oncology Drug Sales by Manufacturers (2015-2020) 3.1.2 Oncology Drug Sales Market Share by Manufacturers (2015-2020) 3.2 Oncology Drug Revenue by Manufacturers 3.2.1 Oncology Drug Revenue by Manufacturers (2015-2020) 3.2.2 Oncology Drug Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Oncology Drug Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Oncology Drug Revenue in 2019 3.2.5 Global Oncology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Oncology Drug Price by Manufacturers 3.4 Oncology Drug Manufacturing Base Distribution, Product Types 3.4.1 Oncology Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Oncology Drug Product Type 3.4.3 Date of International Manufacturers Enter into Oncology Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Oncology Drug Market Size by Type (2015-2020) 4.1.1 Global Oncology Drug Sales by Type (2015-2020) 4.1.2 Global Oncology Drug Revenue by Type (2015-2020) 4.1.3 Oncology Drug Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Oncology Drug Market Size Forecast by Type (2021-2026) 4.2.1 Global Oncology Drug Sales Forecast by Type (2021-2026) 4.2.2 Global Oncology Drug Revenue Forecast by Type (2021-2026) 4.2.3 Oncology Drug Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Oncology Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Oncology Drug Market Size by Application (2015-2020) 5.1.1 Global Oncology Drug Sales by Application (2015-2020) 5.1.2 Global Oncology Drug Revenue by Application (2015-2020) 5.1.3 Oncology Drug Price by Application (2015-2020) 5.2 Oncology Drug Market Size Forecast by Application (2021-2026) 5.2.1 Global Oncology Drug Sales Forecast by Application (2021-2026) 5.2.2 Global Oncology Drug Revenue Forecast by Application (2021-2026) 5.2.3 Global Oncology Drug Price Forecast by Application (2021-2026) 6 North America 6.1 North America Oncology Drug by Country 6.1.1 North America Oncology Drug Sales by Country 6.1.2 North America Oncology Drug Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Oncology Drug Market Facts & Figures by Type 6.3 North America Oncology Drug Market Facts & Figures by Application 7 Europe 7.1 Europe Oncology Drug by Country 7.1.1 Europe Oncology Drug Sales by Country 7.1.2 Europe Oncology Drug Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Oncology Drug Market Facts & Figures by Type 7.3 Europe Oncology Drug Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Oncology Drug by Region 8.1.1 Asia Pacific Oncology Drug Sales by Region 8.1.2 Asia Pacific Oncology Drug Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Oncology Drug Market Facts & Figures by Type 8.3 Asia Pacific Oncology Drug Market Facts & Figures by Application 9 Latin America 9.1 Latin America Oncology Drug by Country 9.1.1 Latin America Oncology Drug Sales by Country 9.1.2 Latin America Oncology Drug Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Oncology Drug Market Facts & Figures by Type 9.3 Central & South America Oncology Drug Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Oncology Drug by Country 10.1.1 Middle East and Africa Oncology Drug Sales by Country 10.1.2 Middle East and Africa Oncology Drug Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Oncology Drug Market Facts & Figures by Type 10.3 Middle East and Africa Oncology Drug Market Facts & Figures by Application 11 Company Profiles 11.1 Roche Ltd 11.1.1 Roche Ltd Corporation Information 11.1.2 Roche Ltd Description and Business Overview 11.1.3 Roche Ltd Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Roche Ltd Oncology Drug Products Offered 11.1.5 Roche Ltd Related Developments 11.2 Novartis AG 11.2.1 Novartis AG Corporation Information 11.2.2 Novartis AG Description and Business Overview 11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Novartis AG Oncology Drug Products Offered 11.2.5 Novartis AG Related Developments 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Corporation Information 11.3.2 Bristol-Myers Squibb Description and Business Overview 11.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Bristol-Myers Squibb Oncology Drug Products Offered 11.3.5 Bristol-Myers Squibb Related Developments 11.4 Celgene Corporation 11.4.1 Celgene Corporation Corporation Information 11.4.2 Celgene Corporation Description and Business Overview 11.4.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Celgene Corporation Oncology Drug Products Offered 11.4.5 Celgene Corporation Related Developments 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Corporation Information 11.5.2 Johnson & Johnson Description and Business Overview 11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Johnson & Johnson Oncology Drug Products Offered 11.5.5 Johnson & Johnson Related Developments 11.6 Pfizer Inc. 11.6.1 Pfizer Inc. Corporation Information 11.6.2 Pfizer Inc. Description and Business Overview 11.6.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Pfizer Inc. Oncology Drug Products Offered 11.6.5 Pfizer Inc. Related Developments 11.7 Astra Zenca Plc 11.7.1 Astra Zenca Plc Corporation Information 11.7.2 Astra Zenca Plc Description and Business Overview 11.7.3 Astra Zenca Plc Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Astra Zenca Plc Oncology Drug Products Offered 11.7.5 Astra Zenca Plc Related Developments 11.8 Eli Lilly And Company. 11.8.1 Eli Lilly And Company. Corporation Information 11.8.2 Eli Lilly And Company. Description and Business Overview 11.8.3 Eli Lilly And Company. Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Eli Lilly And Company. Oncology Drug Products Offered 11.8.5 Eli Lilly And Company. Related Developments 11.9 Glaxosmithkline Plc 11.9.1 Glaxosmithkline Plc Corporation Information 11.9.2 Glaxosmithkline Plc Description and Business Overview 11.9.3 Glaxosmithkline Plc Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Glaxosmithkline Plc Oncology Drug Products Offered 11.9.5 Glaxosmithkline Plc Related Developments 11.10 Merck & Co. 11.10.1 Merck & Co. Corporation Information 11.10.2 Merck & Co. Description and Business Overview 11.10.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Merck & Co. Oncology Drug Products Offered 11.10.5 Merck & Co. Related Developments 11.1 Roche Ltd 11.1.1 Roche Ltd Corporation Information 11.1.2 Roche Ltd Description and Business Overview 11.1.3 Roche Ltd Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Roche Ltd Oncology Drug Products Offered 11.1.5 Roche Ltd Related Developments 11.12 Amgen Inc. 11.12.1 Amgen Inc. Corporation Information 11.12.2 Amgen Inc. Description and Business Overview 11.12.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020) 11.12.4 Amgen Inc. Products Offered 11.12.5 Amgen Inc. Related Developments 11.13 Abbvie 11.13.1 Abbvie Corporation Information 11.13.2 Abbvie Description and Business Overview 11.13.3 Abbvie Sales, Revenue and Gross Margin (2015-2020) 11.13.4 Abbvie Products Offered 11.13.5 Abbvie Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Oncology Drug Market Estimates and Projections by Region 12.1.1 Global Oncology Drug Sales Forecast by Regions 2021-2026 12.1.2 Global Oncology Drug Revenue Forecast by Regions 2021-2026 12.2 North America Oncology Drug Market Size Forecast (2021-2026) 12.2.1 North America: Oncology Drug Sales Forecast (2021-2026) 12.2.2 North America: Oncology Drug Revenue Forecast (2021-2026) 12.2.3 North America: Oncology Drug Market Size Forecast by Country (2021-2026) 12.3 Europe Oncology Drug Market Size Forecast (2021-2026) 12.3.1 Europe: Oncology Drug Sales Forecast (2021-2026) 12.3.2 Europe: Oncology Drug Revenue Forecast (2021-2026) 12.3.3 Europe: Oncology Drug Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Oncology Drug Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Oncology Drug Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Oncology Drug Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Oncology Drug Market Size Forecast by Region (2021-2026) 12.5 Latin America Oncology Drug Market Size Forecast (2021-2026) 12.5.1 Latin America: Oncology Drug Sales Forecast (2021-2026) 12.5.2 Latin America: Oncology Drug Revenue Forecast (2021-2026) 12.5.3 Latin America: Oncology Drug Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Oncology Drug Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Oncology Drug Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Oncology Drug Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Oncology Drug Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Oncology Drug Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Oncology Drug Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Oncology Drug Market Segments Table 2. Ranking of Global Top Oncology Drug Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Oncology Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million) Table 4. Major Manufacturers of Chemotherapy Table 5. Major Manufacturers of Targeted Therapy Table 6. Major Manufacturers of Immunotherapy Table 7. Major Manufacturers of Hormonal Therapy Table 8. Major Manufacturers of Others Table 9. Global Oncology Drug Market Size Growth Rate by Application 2020-2026 (K MT) Table 10. Global Oncology Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026 Table 11. Global Oncology Drug Sales by Regions 2015-2020 (K MT) Table 12. Global Oncology Drug Sales Market Share by Regions (2015-2020) Table 13. Global Oncology Drug Revenue by Regions 2015-2020 (US$ Million) Table 14. Global Oncology Drug Sales by Manufacturers (2015-2020) (K MT) Table 15. Global Oncology Drug Sales Share by Manufacturers (2015-2020) Table 16. Global Oncology Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 17. Global Oncology Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drug as of 2019) Table 18. Oncology Drug Revenue by Manufacturers (2015-2020) (US$ Million) Table 19. Oncology Drug Revenue Share by Manufacturers (2015-2020) Table 20. Key Manufacturers Oncology Drug Price (2015-2020) (USD/MT) Table 21. Oncology Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Oncology Drug Product Type Table 23. Date of International Manufacturers Enter into Oncology Drug Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Oncology Drug Sales by Type (2015-2020) (K MT) Table 26. Global Oncology Drug Sales Share by Type (2015-2020) Table 27. Global Oncology Drug Revenue by Type (2015-2020) (US$ Million) Table 28. Global Oncology Drug Revenue Share by Type (2015-2020) Table 29. Oncology Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT) Table 30. Global Oncology Drug Sales by Application (2015-2020) (K MT) Table 31. Global Oncology Drug Sales Share by Application (2015-2020) Table 32. North America Oncology Drug Sales by Country (2015-2020) (K MT) Table 33. North America Oncology Drug Sales Market Share by Country (2015-2020) Table 34. North America Oncology Drug Revenue by Country (2015-2020) (US$ Million) Table 35. North America Oncology Drug Revenue Market Share by Country (2015-2020) Table 36. North America Oncology Drug Sales by Type (2015-2020) (K MT) Table 37. North America Oncology Drug Sales Market Share by Type (2015-2020) Table 38. North America Oncology Drug Sales by Application (2015-2020) (K MT) Table 39. North America Oncology Drug Sales Market Share by Application (2015-2020) Table 40. Europe Oncology Drug Sales by Country (2015-2020) (K MT) Table 41. Europe Oncology Drug Sales Market Share by Country (2015-2020) Table 42. Europe Oncology Drug Revenue by Country (2015-2020) (US$ Million) Table 43. Europe Oncology Drug Revenue Market Share by Country (2015-2020) Table 44. Europe Oncology Drug Sales by Type (2015-2020) (K MT) Table 45. Europe Oncology Drug Sales Market Share by Type (2015-2020) Table 46. Europe Oncology Drug Sales by Application (2015-2020) (K MT) Table 47. Europe Oncology Drug Sales Market Share by Application (2015-2020) Table 48. Asia Pacific Oncology Drug Sales by Region (2015-2020) (K MT) Table 49. Asia Pacific Oncology Drug Sales Market Share by Region (2015-2020) Table 50. Asia Pacific Oncology Drug Revenue by Region (2015-2020) (US$ Million) Table 51. Asia Pacific Oncology Drug Revenue Market Share by Region (2015-2020) Table 52. Asia Pacific Oncology Drug Sales by Type (2015-2020) (K MT) Table 53. Asia Pacific Oncology Drug Sales Market Share by Type (2015-2020) Table 54. Asia Pacific Oncology Drug Sales by Application (2015-2020) (K MT) Table 55. Asia Pacific Oncology Drug Sales Market Share by Application (2015-2020) Table 56. Latin America Oncology Drug Sales by Country (2015-2020) (K MT) Table 57. Latin America Oncology Drug Sales Market Share by Country (2015-2020) Table 58. Latin Americaa Oncology Drug Revenue by Country (2015-2020) (US$ Million) Table 59. Latin America Oncology Drug Revenue Market Share by Country (2015-2020) Table 60. Latin America Oncology Drug Sales by Type (2015-2020) (K MT) Table 61. Latin America Oncology Drug Sales Market Share by Type (2015-2020) Table 62. Latin America Oncology Drug Sales by Application (2015-2020) (K MT) Table 63. Latin America Oncology Drug Sales Market Share by Application (2015-2020) Table 64. Middle East and Africa Oncology Drug Sales by Country (2015-2020) (K MT) Table 65. Middle East and Africa Oncology Drug Sales Market Share by Country (2015-2020) Table 66. Middle East and Africa Oncology Drug Revenue by Country (2015-2020) (US$ Million) Table 67. Middle East and Africa Oncology Drug Revenue Market Share by Country (2015-2020) Table 68. Middle East and Africa Oncology Drug Sales by Type (2015-2020) (K MT) Table 69. Middle East and Africa Oncology Drug Sales Market Share by Type (2015-2020) Table 70. Middle East and Africa Oncology Drug Sales by Application (2015-2020) (K MT) Table 71. Middle East and Africa Oncology Drug Sales Market Share by Application (2015-2020) Table 72. Roche Ltd Corporation Information Table 73. Roche Ltd Description and Major Businesses Table 74. Roche Ltd Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 75. Roche Ltd Product Table 76. Roche Ltd Recent Development Table 77. Novartis AG Corporation Information Table 78. Novartis AG Description and Major Businesses Table 79. Novartis AG Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 80. Novartis AG Product Table 81. Novartis AG Recent Development Table 82. Bristol-Myers Squibb Corporation Information Table 83. Bristol-Myers Squibb Description and Major Businesses Table 84. Bristol-Myers Squibb Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 85. Bristol-Myers Squibb Product Table 86. Bristol-Myers Squibb Recent Development Table 87. Celgene Corporation Corporation Information Table 88. Celgene Corporation Description and Major Businesses Table 89. Celgene Corporation Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 90. Celgene Corporation Product Table 91. Celgene Corporation Recent Development Table 92. Johnson & Johnson Corporation Information Table 93. Johnson & Johnson Description and Major Businesses Table 94. Johnson & Johnson Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 95. Johnson & Johnson Product Table 96. Johnson & Johnson Recent Development Table 97. Pfizer Inc. Corporation Information Table 98. Pfizer Inc. Description and Major Businesses Table 99. Pfizer Inc. Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 100. Pfizer Inc. Product Table 101. Pfizer Inc. Recent Development Table 102. Astra Zenca Plc Corporation Information Table 103. Astra Zenca Plc Description and Major Businesses Table 104. Astra Zenca Plc Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 105. Astra Zenca Plc Product Table 106. Astra Zenca Plc Recent Development Table 107. Eli Lilly And Company. Corporation Information Table 108. Eli Lilly And Company. Description and Major Businesses Table 109. Eli Lilly And Company. Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 110. Eli Lilly And Company. Product Table 111. Eli Lilly And Company. Recent Development Table 112. Glaxosmithkline Plc Corporation Information Table 113. Glaxosmithkline Plc Description and Major Businesses Table 114. Glaxosmithkline Plc Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 115. Glaxosmithkline Plc Product Table 116. Glaxosmithkline Plc Recent Development Table 117. Merck & Co. Corporation Information Table 118. Merck & Co. Description and Major Businesses Table 119. Merck & Co. Oncology Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 120. Merck & Co. Product Table 121. Merck & Co. Recent Development Table 122. Sanofi Corporation Information Table 123. Sanofi Description and Major Businesses Table 124. Sanofi Oncology Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 125. Sanofi Product Table 126. Sanofi Recent Development Table 127. Amgen Inc. Corporation Information Table 128. Amgen Inc. Description and Major Businesses Table 129. Amgen Inc. Oncology Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 130. Amgen Inc. Product Table 131. Amgen Inc. Recent Development Table 132. Abbvie Corporation Information Table 133. Abbvie Description and Major Businesses Table 134. Abbvie Oncology Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 135. Abbvie Product Table 136. Abbvie Recent Development Table 137. Global Oncology Drug Sales Forecast by Regions (2021-2026) (K MT) Table 138. Global Oncology Drug Sales Market Share Forecast by Regions (2021-2026) Table 139. Global Oncology Drug Revenue Forecast by Regions (2021-2026) (US$ Million) Table 140. Global Oncology Drug Revenue Market Share Forecast by Regions (2021-2026) Table 141. North America: Oncology Drug Sales Forecast by Country (2021-2026) (K MT) Table 142. North America: Oncology Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 143. Europe: Oncology Drug Sales Forecast by Country (2021-2026) (K MT) Table 144. Europe: Oncology Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 145. Asia Pacific: Oncology Drug Sales Forecast by Region (2021-2026) (K MT) Table 146. Asia Pacific: Oncology Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 147. Latin America: Oncology Drug Sales Forecast by Country (2021-2026) (K MT) Table 148. Latin America: Oncology Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 149. Middle East and Africa: Oncology Drug Sales Forecast by Country (2021-2026) (K MT) Table 150. Middle East and Africa: Oncology Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 151. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 152. Key Challenges Table 153. Market Risks Table 154. Main Points Interviewed from Key Oncology Drug Players Table 155. Oncology Drug Customers List Table 156. Oncology Drug Distributors List Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Oncology Drug Product Picture Figure 2. Global Oncology Drug Sales Market Share by Type in 2020 & 2026 Figure 3. Chemotherapy Product Picture Figure 4. Targeted Therapy Product Picture Figure 5. Immunotherapy Product Picture Figure 6. Hormonal Therapy Product Picture Figure 7. Others Product Picture Figure 8. Global Oncology Drug Sales Market Share by Application in 2020 & 2026 Figure 9. Blood Cancer Figure 10. Breast Cancer Figure 11. gastrointestinal Tract Cancer Figure 12. Prostate Cancer Figure 13. Lung Cancer Figure 14. Skin Cancer Figure 15. Oncology Drug Report Years Considered Figure 16. Global Oncology Drug Market Size 2015-2026 (US$ Million) Figure 17. Global Oncology Drug Sales 2015-2026 (K MT) Figure 18. Global Oncology Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 19. Global Oncology Drug Sales Market Share by Region (2015-2020) Figure 20. Global Oncology Drug Sales Market Share by Region in 2019 Figure 21. Global Oncology Drug Revenue Market Share by Region (2015-2020) Figure 22. Global Oncology Drug Revenue Market Share by Region in 2019 Figure 23. Global Oncology Drug Sales Share by Manufacturer in 2019 Figure 24. The Top 10 and 5 Players Market Share by Oncology Drug Revenue in 2019 Figure 25. Oncology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 26. Global Oncology Drug Sales Market Share by Type (2015-2020) Figure 27. Global Oncology Drug Sales Market Share by Type in 2019 Figure 28. Global Oncology Drug Revenue Market Share by Type (2015-2020) Figure 29. Global Oncology Drug Revenue Market Share by Type in 2019 Figure 30. Global Oncology Drug Market Share by Price Range (2015-2020) Figure 31. Global Oncology Drug Sales Market Share by Application (2015-2020) Figure 32. Global Oncology Drug Sales Market Share by Application in 2019 Figure 33. Global Oncology Drug Revenue Market Share by Application (2015-2020) Figure 34. Global Oncology Drug Revenue Market Share by Application in 2019 Figure 35. North America Oncology Drug Sales Growth Rate 2015-2020 (K MT) Figure 36. North America Oncology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 37. North America Oncology Drug Sales Market Share by Country in 2019 Figure 38. North America Oncology Drug Revenue Market Share by Country in 2019 Figure 39. U.S. Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 40. U.S. Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Canada Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 42. Canada Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. North America Oncology Drug Market Share by Type in 2019 Figure 44. North America Oncology Drug Market Share by Application in 2019 Figure 45. Europe Oncology Drug Sales Growth Rate 2015-2020 (K MT) Figure 46. Europe Oncology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 47. Europe Oncology Drug Sales Market Share by Country in 2019 Figure 48. Europe Oncology Drug Revenue Market Share by Country in 2019 Figure 49. Germany Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 50. Germany Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. France Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 52. France Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. U.K. Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 54. U.K. Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Italy Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 56. Italy Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Russia Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 58. Russia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Europe Oncology Drug Market Share by Type in 2019 Figure 60. Europe Oncology Drug Market Share by Application in 2019 Figure 61. Asia Pacific Oncology Drug Sales Growth Rate 2015-2020 (K MT) Figure 62. Asia Pacific Oncology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 63. Asia Pacific Oncology Drug Sales Market Share by Region in 2019 Figure 64. Asia Pacific Oncology Drug Revenue Market Share by Region in 2019 Figure 65. China Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 66. China Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Japan Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 68. Japan Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. South Korea Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 70. South Korea Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. India Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 72. India Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Australia Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 74. Australia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Taiwan Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 76. Taiwan Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Indonesia Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 78. Indonesia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Thailand Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 80. Thailand Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Malaysia Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 82. Malaysia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Philippines Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 84. Philippines Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Vietnam Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 86. Vietnam Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 87. Asia Pacific Oncology Drug Market Share by Type in 2019 Figure 88. Asia Pacific Oncology Drug Market Share by Application in 2019 Figure 89. Latin America Oncology Drug Sales Growth Rate 2015-2020 (K MT) Figure 90. Latin America Oncology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 91. Latin America Oncology Drug Sales Market Share by Country in 2019 Figure 92. Latin America Oncology Drug Revenue Market Share by Country in 2019 Figure 93. Mexico Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 94. Mexico Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Brazil Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 96. Brazil Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Argentina Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 98. Argentina Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 99. Latin America Oncology Drug Market Share by Type in 2019 Figure 100. Latin America Oncology Drug Market Share by Application in 2019 Figure 101. Middle East and Africa Oncology Drug Sales Growth Rate 2015-2020 (K MT) Figure 102. Middle East and Africa Oncology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 103. Middle East and Africa Oncology Drug Sales Market Share by Country in 2019 Figure 104. Middle East and Africa Oncology Drug Revenue Market Share by Country in 2019 Figure 105. Turkey Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 106. Turkey Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. Saudi Arabia Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 108. Saudi Arabia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 109. U.A.E Oncology Drug Sales Growth Rate (2015-2020) (K MT) Figure 110. U.A.E Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 111. Middle East and Africa Oncology Drug Market Share by Type in 2019 Figure 112. Middle East and Africa Oncology Drug Market Share by Application in 2019 Figure 113. North America Oncology Drug Sales Growth Rate Forecast (2021-2026) (K MT) Figure 114. North America Oncology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Europe Oncology Drug Sales Growth Rate Forecast (2021-2026) (K MT) Figure 116. Europe Oncology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Asia Pacific Oncology Drug Sales Growth Rate Forecast (2021-2026) (K MT) Figure 118. Asia Pacific Oncology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 119. Latin America Oncology Drug Sales Growth Rate Forecast (2021-2026) (K MT) Figure 120. Latin America Oncology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 121. Middle East and Africa Oncology Drug Sales Growth Rate Forecast (2021-2026) (K MT) Figure 122. Middle East and Africa Oncology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 123. Porter's Five Forces Analysis Figure 124. Channels of Distribution Figure 125. Distributors Profiles Figure 126. Bottom-up and Top-down Approaches for This Report Figure 127. Data Triangulation Figure 128. Key Executives Interviewed

Get Free Sample

Related Reports

Global Oncology Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Oncology Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Oncology Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Oncology Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Oncology Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)